FAREVA is among the European leaders in contract manufacturing and services for the Pharmaceutical industry in formulation products and API. In this field we offer a large scope of technologies for API and formulations (ophthalmic sterile liquids, sterile ointments, creams and gels, aerosols, solid forms including under high read morecontainment environment, injectables, semi liquid and liquid forms, suspensions, syrups, gels, food supplements). FAREVA API manufactures in two FDA approved sites and can provide excellent process development and niche specialities like steroid chemistry, aseptic processing and high containment operations. Fareva API operates in France under the name of Valedpharm (former Pharmacia & Upjohn / Pfizer) and in Germany [website]

Welcome to Fermion! We are one of the leading companies active in API’s for the innovative and generic drugs industry. Founded in 1969 as a company developing products through fermentation and being a daughter company of Orion Corporation, we offer Contract Research and Manufacturing Services to third parties read moreworldwide. Ten innovative products, for which Fermion developed the API, have either been filed or launched/commercialized worldwide.

We offer partnering for in-licensing and co-marketing, contract manufacturing for dosage forms, contract manufacturing for small-scale APIs and being competitive in the API space by co-operating with partners for procuring early intermediates. We have two FDA-inspected plants and manufacture more than 220 tons of API per year. [website]

F.I.S. – Fabbrica Italiana Sintetici is a private Italian company that specializes in API production.

Custom Synthesis is our core business, which means the exclusive production of intermediates, advanced intermediates and APIs for pharmaceutical companies who will own the NDA. FIS has the capability to read moreprovide a wide array of integrated services to the customer, including process research and development, optimization, and scale-up facilities to support both validation and commercial launch.

FIS also develops and sells a wide range of Generic APIs including anxiolytics, anticonvulsants, antidepressants, analgesics, anti- inflammatory agents, antibacterials, antifungals, cardiovascular drugs, and diuretics. [website]

Since 1950, FLAMMA continues to be one of the preeminent manufacturers of high value chiral APIs and intermediates for the pharmaceutical industry. Are you making small peptides or molecules containing natural and/or unnatural amino acids? If so, FLAMMA makes sense as a CMO. Numerous top 20 pharma/biotechs understand read morethe value that FLAMMA brings and work with our team as one of their preferred suppliers.

FLAMMA has 3 manufacturing facilities all with R&D & kilo labs for small scale needs. Both Italian locations (Chignolo & Isso) are cGMP facilities that are regularly inspected by the FDA, AIFA, & customers. FLAMMA's Dalian, China facilities feature a non-cGMP production plant.

FLAMMA is fully integrated and leverages their self-owned, self-managed facilities in China to deliver results. FLAMMA reliably supplies materials directly customers and/or they deliver materials (when required) to their cGMP facilities in Italy in order to deliver the customer's compound on-time with the required specifications. FLAMMA offers cost-effective services to customers looking for a trusted partner within China.

With a total capacity of 360 m³ & over 300 employees, find out why FLAMMA should be a CMO you consider for your next project.